Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

7.18
Delayed Data
As of Jul 22
 -0.12 / -1.64%
Today’s Change
5.27
Today|||52-Week Range
60.93
-77.84%
Year-to-Date

Today’s Trading

Previous close7.30
Today’s open7.31
Day’s range7.12 - 7.54
Volume478,974
Average volume (3 months)1,508,349
Market cap$246.0M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-70.71%
Earnings growth (this year)+3.90%
Earnings growth (next 5 years)--
Revenue growth (last year)+45.64%
P/E ratioNM
Price/Sales29.63
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
SELBSelecta Biosciences ...-0.24-1.71%
SRNESorrento Therapeutic...0.000.00%
KPTIKaryopharm Therapeut...-0.11-1.54%
CNCEConcert Pharmaceutic...-0.02-0.17%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$36.8M
Annual profit (last year)-$170.4M
Net profit margin-463.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Executive VP-Research, Operations &
Technology
Neil Gregory Almstead
Corporate headquarters
South Plainfield, New Jersey

Forecasts

Partner Offers

Search for Jobs